Megatas S 50 Tablet ER

Overview Megatas S 50 Tablet ER

Extended-release Megatas S 50 tablets combine two medications to manage overactive bladder symptoms. This treatment alleviates urinary frequency, urgency, and incontinence. Dosage and duration should strictly follow your physician's instructions. The medication can be taken with or without food, ideally at the same time daily. Discontinuing use without medical consultation may exacerbate symptoms; complete the prescribed course for optimal results. Common side effects include elevated blood pressure, inflammation of the nose and throat (nasopharyngitis), urinary tract infections, and headaches. Report any persistent or bothersome side effects promptly to your doctor. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment require close monitoring and regular check-ups as directed by their doctor.

Uses of Megatas S 50 Tablet ER

Symptoms associated with an overactive bladder

Major Benefits of Megatas S 50 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megatas S 50 Tablet ER can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Megatas S 50 Tablet ER:

• High blood pressure
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Dryness in mouth
• Constipation
• Increased heart rate
• Blurred vision

How to use Megatas S 50 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Megatas S 50 Tablet ER can be consumed with or without food, although consistent timing is recommended.

How Megatas S 50 Tablet ER works:

Megatas S 50 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism, also relaxing bladder muscles. This dual action reduces the frequency, urgency, and involuntary urges associated with overactive bladder.

What if you forget to take Megatas S 50 Tablet ER :

NA